Ido Har-Shalom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ido Har-Shalom has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arnon Karni
Tel Aviv University
1 shared publication Aviv Jarbi
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication- Hadar Kolb
Department of Neurology, Sourasky Tel Aviv Medical Center, Tel Aviv, Israel
1 shared publication - Meytal Wilf
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Michal Ramot
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Michal Zamberg-Elad
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication
Latest Publications
- Open Access
From Consensus to Individual Differences: Typicality Links Brain and Behavior Across Naturalistic Contexts
When people experience the same naturalistic events, their brains and behavior converge on remarkably similar responses. This shared response is widely used to identify what people have in common, but whether the consensus itself carries meaning has remained largely unexplored. Here we propose that the group consensus is not merely an average, but an approximation of a shared solution to the computation being performed, such that an individual’s proximity to it, their typicality, indexes how well they perform that computation. Across behavioral tasks spanning social and non-social cognition, typicality was a stable characteristic of the individual, yet specific to the computation engaged rather than a general tendency to conform. Neural typicality during movie viewing showed the same organization, and was linked to behavior most strongly where the relevant computation was engaged: typicality in face-selective cortex was more strongly related to behavior on tasks involving faces than on matched tasks without faces, particularly during movies containing faces. Critically, where ground truth was available, proximity to the consensus predicted objective performance: neural typicality measured during passive movie viewing predicted accuracy on independent motion-prediction and face-recognition tasks. These findings suggest that, when individuals share objectives and constraints, the group consensus can serve as an empirical benchmark of successful processing, offering a principled way to measure individual differences in complex behaviors for which no correct answer can be defined. Significance Statement: Many complex human behaviors, such as interpreting another person’s emotions, have no single “correct” response, making them difficult to quantify using traditional measures. We propose that the response people converge on when experiencing the same events is not merely an average, but an approximation of a shared solution, so that how closely an individual approaches it, their typicality, can serve as a measure of performance. We show that typicality is a stable characteristic of the individual, specific to the type of information being processed, and linked to the brain systems supporting it. Where correct answers exist, people whose brain responses during movie viewing were more typical performed better on independent tasks. These findings provide a new way to study individual differences in complex, real-world behavior and suggest that shared responses may, under appropriate conditions, reveal how effectively information is being processed.
Open AccessFrom Consensus to Individual Differences: Typicality Links Brain and Behavior Across Naturalistic Contexts
When people experience the same naturalistic events, their brains and behavior converge on remarkably similar responses. This shared response is widely used to identify what people have in common, but whether the consensus itself carries meaning has remained largely unexplored. Here we propose that the group consensus is not merely an average, but an approximation of a shared solution to the computation being performed, such that an individual’s proximity to it, their typicality, indexes how well they perform that computation. Across behavioral tasks spanning social and non-social cognition, typicality was a stable characteristic of the individual, yet specific to the computation engaged rather than a general tendency to conform. Neural typicality during movie viewing showed the same organization, and was linked to behavior most strongly where the relevant computation was engaged: typicality in face-selective cortex was more strongly related to behavior on tasks involving faces than on matched tasks without faces, particularly during movies containing faces. Critically, where ground truth was available, proximity to the consensus predicted objective performance: neural typicality measured during passive movie viewing predicted accuracy on independent motion-prediction and face-recognition tasks. These findings suggest that, when individuals share objectives and constraints, the group consensus can serve as an empirical benchmark of successful processing, offering a principled way to measure individual differences in complex behaviors for which no correct answer can be defined. Significance Statement: Many complex human behaviors, such as interpreting another person’s emotions, have no single “correct” response, making them difficult to quantify using traditional measures. We propose that the response people converge on when experiencing the same events is not merely an average, but an approximation of a shared solution, so that how closely an individual approaches it, their typicality, can serve as a measure of performance. We show that typicality is a stable characteristic of the individual, specific to the type of information being processed, and linked to the brain systems supporting it. Where correct answers exist, people whose brain responses during movie viewing were more typical performed better on independent tasks. These findings provide a new way to study individual differences in complex, real-world behavior and suggest that shared responses may, under appropriate conditions, reveal how effectively information is being processed.
- Open Access
- 31 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 474
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
The appearance of new disease-modifying therapies in multiple sclerosis (MS) has revolutionized our ability to fight inflammatory relapses and has immensely improved patients’ quality of life. Although remarkable, this achievement has not carried over into reducing long-term disability. In MS, clinical disability progression can continue relentlessly irrespective of acute inflammation. This “silent” disease progression is the main contributor to long-term clinical disability in MS and results from chronic inflammation, neurodegeneration, and repair failure. Investigating silent disease progression and its underlying mechanisms is a challenge. Standard MRI excels in depicting acute inflammation but lacks the pathophysiological lens required for a more targeted exploration of molecular-based processes. Novel modalities that utilize nuclear magnetic resonance’s ability to display in vivo information on imaging look to bridge this gap. Displaying the CNS through a molecular prism is becoming an undeniable reality. This review will focus on “molecular imaging biomarkers” of disease progression, modalities that can harmoniously depict anatomy and pathophysiology, making them attractive candidates to become the first valid biomarkers of neuroprotection and remyelination.
- 31 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 474
Open AccessThe Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
The appearance of new disease-modifying therapies in multiple sclerosis (MS) has revolutionized our ability to fight inflammatory relapses and has immensely improved patients’ quality of life. Although remarkable, this achievement has not carried over into reducing long-term disability. In MS, clinical disability progression can continue relentlessly irrespective of acute inflammation. This “silent” disease progression is the main contributor to long-term clinical disability in MS and results from chronic inflammation, neurodegeneration, and repair failure. Investigating silent disease progression and its underlying mechanisms is a challenge. Standard MRI excels in depicting acute inflammation but lacks the pathophysiological lens required for a more targeted exploration of molecular-based processes. Novel modalities that utilize nuclear magnetic resonance’s ability to display in vivo information on imaging look to bridge this gap. Displaying the CNS through a molecular prism is becoming an undeniable reality. This review will focus on “molecular imaging biomarkers” of disease progression, modalities that can harmoniously depict anatomy and pathophysiology, making them attractive candidates to become the first valid biomarkers of neuroprotection and remyelination.